• Non ci sono risultati.

What is the optimal current axillary management after NAC?

N/A
N/A
Protected

Academic year: 2022

Condividi "What is the optimal current axillary management after NAC?"

Copied!
86
0
0

Testo completo

(1)

What is the optimal current axillary management after NAC?

Alessandra Cassano

Oncologia Medica

(2)
(3)
(4)

Methods to minimize the False Negative Rate (FNR) of sentinel lymph node dissection after neoadjuvant chemotherapy for

node positive breast cancer

Practical approach to the axilla after neoadjuvant chemotherapy:

What the clinical trials don't address

(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)
(61)
(62)
(63)
(64)
(65)
(66)
(67)
(68)
(69)
(70)
(71)
(72)
(73)
(74)
(75)
(76)
(77)
(78)
(79)
(80)
(81)
(82)
(83)
(84)
(85)
(86)

Riferimenti

Documenti correlati

The neutrophil to lymphocyte ratio has a high negative predictive value for pathologic complete response in locally advanced breast cancer patients receiving neoadjuvant

Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study.. Sonoda,

Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Motomura K, Komoike Y, Hasegawa Y, Kasugai

performance of magnetic resonance imaging for assessing tumor response in patients with HER2- negative breast cancer receiving neoadjuvant chemotherapy is associated with

head, neck and upper GI cancer, 211 melanoma and breast cancer, 210 nonsmall cell lung cancer, 213, 214 sentinel lymph node concept.

SLN biopsy is an appropriate initial alternative to routine staging axillary lymph node dissection for patients with early- stage breast cancer with clinically negative axillary

Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta - analysis of randomized clinical trials.. Crit Rev

He treated penile cancer patients without the dissection of in- guinal, femoral, and iliacal lymph nodes when the sentinel node was tumor free.. The 5-year survival rate of his